Two major pharmaceutical companies — GlaxoSmithKline and Pfizer — recently changed their continuing medical education granting process to eliminate medical education and communication companies as prospective recipients of unrestricted grants. To many CME providers, this seems like a vote of no confidence in MECCs' ability to provide high-quality, independent, unbiased, and effective CME, compared to societies, academic centers, and others who provide accredited CME. What w
2009 Annual Physicians' CME Preferences Survey
Two-thirds of physicians surveyed believe the quality of the continuing medical education they receive varies depending on the type of provider. The question is, whom do they trust?